Complete Filing Data
HeartBeam, Inc. reported Stockholders Equity of $2.60 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean HeartBeam, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Research And Development Expense | $13.5M | $11.1M | $6.8M | $5.7M | $255.0K | $133.0K |
| Operating Income Loss | -$21.1M | -$19.9M | -$15.3M | -$13.0M | -$2.3M | -$788.0K |
| Operating Expenses | $21.1M | $19.9M | $15.3M | $13.0M | $2.3M | $788.0K |
| Nonoperating Income Expense | $124.0K | $439.0K | $675.0K | $69.0K | -$2.1M | -$280.0K |
| Net Income Loss | -$21.0M | -$19.4M | -$14.6M | -$13.0M | -$4.4M | -$1.1M |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$21.0M | -$19.4M | -$14.6M | -$13.0M | -$4.4M | -$1.1M |
| General And Administrative Expense | $7.7M | $8.8M | $8.5M | $7.4M | $2.0M | $655.0K |
| Interest Income Expense Nonoperating Net | $122.0K | $446.0K | $675.0K | $66.0K | -$2.2M | |
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Nonoperating Income Expense | $2.0K | -$7.0K | $0.00 | $3.0K | $22.0K | $0.00 |
| Interest Expense | $2.2M | $280.0K | ||||
| Selling General And Administrative Expense |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research And Development Expense | $3.3M | $3.3M | $3.5M | $2.9M | $2.8M | $2.4M | $1.6M | $1.5M | $1.7M | $1.6M | $1.7M | $734.0K | $105.0K | $25.0K | $29.0K | $57.0K |
| Operating Income Loss | -$5.3M | -$5.0M | -$5.5M | -$5.1M | -$5.1M | -$4.8M | -$3.7M | -$3.3M | -$4.2M | -$3.6M | -$3.5M | -$2.1M | -$446.0K | -$337.0K | -$163.0K | -$272.0K |
| Operating Expenses | $5.3M | $5.0M | $5.5M | $5.1M | $5.1M | $4.8M | $3.7M | $3.3M | $4.2M | $3.6M | $3.5M | $2.1M | $446.0K | $337.0K | $163.0K | $272.0K |
| Nonoperating Income Expense | $35.0K | $63.0K | $20.0K | $90.0K | $134.0K | $178.0K | $267.0K | $158.0K | $20.0K | $31.0K | $10.0K | $2.0K | -$742.0K | -$608.0K | -$47.0K | $0.00 |
| Net Income Loss | -$5.3M | -$5.0M | -$5.5M | -$5.0M | -$5.0M | -$4.6M | -$3.5M | -$3.2M | -$4.1M | -$3.6M | -$3.5M | -$2.1M | -$1.2M | -$945.0K | -$210.0K | -$335.0K |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$5.3M | -$5.0M | -$5.5M | -$5.0M | -$5.0M | -$4.6M | -$3.5M | -$3.2M | -$4.1M | -$3.6M | -$3.5M | -$2.1M | -$1.2M | -$945.0K | -$210.0K | -$335.0K |
| General And Administrative Expense | $2.0M | $1.7M | $2.0M | $2.2M | $2.2M | $2.4M | $2.1M | $1.8M | $2.5M | $2.0M | $1.8M | $1.4M | $341.0K | $312.0K | $134.0K | |
| Interest Income Expense Nonoperating Net | $36.0K | $63.0K | $20.0K | $96.0K | $134.0K | $178.0K | $267.0K | $158.0K | $20.0K | $28.0K | $10.0K | $2.0K | -$742.0K | -$608.0K | -$69.0K | |
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | |||||||||||||
| Other Nonoperating Income Expense | -$6.0K | $0.00 | $3.0K | $0.00 | $0.00 | $0.00 | $0.00 | $22.0K | ||||||||
| Interest Expense | $742.0K | $63.0K | ||||||||||||||
| Selling General And Administrative Expense | $341.0K | $215.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $2.6M | $1.7M | $15.9M | $2.4M | $13.4M | -$4.8M | -$3.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.4M | $2.4M | $16.2M | $3.6M | $13.2M | $24.0K | $5.0K |
| Cash And Cash Equivalents At Carrying Value | $4.4M | $2.4M | $16.2M | $3.6M | $13.2M | ||
| Retained Earnings Accumulated Deficit | -$77.3M | -$56.3M | -$36.8M | -$22.2M | -$9.2M | -$4.8M | |
| Prepaid Expense And Other Assets Current | $202.0K | $393.0K | $636.0K | $445.0K | $806.0K | $27.0K | |
| Liabilities And Stockholders Equity | $5.8M | $3.3M | $17.1M | $4.0M | $14.0M | $51.0K | |
| Liabilities | $3.2M | $1.6M | $1.2M | $1.7M | $588.0K | $4.8M | |
| Common Stock Value | $4.0K | $3.0K | $3.0K | $1.0K | $1.0K | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $2.0M | -$13.8M | $12.6M | -$9.6M | $13.2M | $19.0K | |
| Assets | $5.8M | $3.3M | $17.1M | $4.0M | $14.0M | $51.0K | |
| Accounts Payable And Accrued Liabilities Current | $1.7M | $588.0K | $489.0K | ||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Restricted Cash Noncurrent | $56.0K | $56.0K | $50.0K | $0.00 | |||
| Assets Current | $4.7M | $2.8M | $16.8M | $4.0M | |||
| Property Plant And Equipment Net | $1.1M | $450.0K | $256.0K | $0.00 | |||
| Other Assets Noncurrent | $56.0K | $56.0K | $50.0K | $0.00 | |||
| Liabilities Current | |||||||
| Debt Conversion Converted Instrument Amount1 | $0.00 | $6.3M | $0.00 | ||||
| Accrued Liabilities Current | $2.2M | $1.1M | $638.0K | ||||
| Accounts Payable Current | $1.1M | $531.0K | $556.0K | ||||
| Repayments Of Short Term Debt | $0.00 | $30.0K | $20.0K | ||||
| Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current | |||||||
| Debt Discount Incurred But Not Yet Recognized | $0.00 | $1.9M | $0.00 | ||||
| Cash | $4.4M | $2.4M | $16.2M | $3.6M | $13.2M | ||
| Adjustment To Additional Paid In Capital Debt Discount Share Settled Debt |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $406.0K | $4.2M | $7.5M | $4.8M | $8.7M | $12.5M | $18.6M | $21.1M | -$859.0K | $5.7M | $9.0M | $12.2M | -$5.2M | -$4.3M | -$5.0M | -$4.5M | -$4.1M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.9M | $3.3M | $4.4M | $5.8M | $9.2M | $12.7M | $19.2M | $17.4M | $990.0K | $6.5M | $9.3M | $11.2M | $795.0K | $465.0K | $84.0K | $236.0K | |||||
| Cash And Cash Equivalents At Carrying Value | $1.9M | $3.3M | $4.4M | $5.8M | $9.2M | $12.6M | $19.2M | $17.4M | $990.0K | $6.5M | $9.3M | ||||||||||
| Retained Earnings Accumulated Deficit | -$72.0M | -$66.7M | -$61.8M | -$51.4M | -$46.4M | -$41.4M | -$32.9M | -$29.5M | -$26.3M | -$18.5M | -$14.9M | -$11.4M | -$7.1M | ||||||||
| Prepaid Expense And Other Assets Current | $270.0K | $308.0K | $458.0K | $376.0K | $544.0K | $599.0K | $295.0K | $292.0K | $471.0K | $123.0K | $464.0K | $1.5M | $166.0K | ||||||||
| Liabilities And Stockholders Equity | $2.9M | $6.0M | $9.1M | $6.7M | $10.1M | $13.6M | $19.6M | $21.6M | $1.5M | $6.7M | $9.7M | $12.7M | $961.0K | ||||||||
| Liabilities | $2.5M | $1.8M | $1.6M | $1.9M | $1.4M | $1.1M | $1.0M | $570.0K | $2.3M | $932.0K | $770.0K | $514.0K | $6.1M | ||||||||
| Common Stock Value | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0.00 | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $2.0M | -$3.6M | -$2.6M | -$2.0M | $60.0K | ||||||||||||||||
| Assets | $2.9M | $6.0M | $9.1M | $6.7M | $10.1M | $13.6M | $19.6M | $6.7M | $9.7M | $12.7M | $961.0K | ||||||||||
| Accounts Payable And Accrued Liabilities Current | $1.9M | $1.4M | $1.1M | $1.2M | $1.0M | $570.0K | $2.3M | $932.0K | $770.0K | $514.0K | $699.0K | ||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||
| Restricted Cash Noncurrent | $56.0K | $56.0K | $56.0K | $56.0K | $55.0K | $50.0K | $25.0K | $0.00 | $0.00 | $0.00 | |||||||||||
| Assets Current | $2.1M | $5.4M | $8.6M | $6.1M | $9.7M | $13.2M | $19.5M | $21.6M | $1.5M | ||||||||||||
| Property Plant And Equipment Net | $694.0K | $564.0K | $443.0K | $457.0K | $370.0K | $344.0K | $144.0K | ||||||||||||||
| Other Assets Noncurrent | $56.0K | $56.0K | $56.0K | $56.0K | $55.0K | $54.0K | $25.0K | ||||||||||||||
| Liabilities Current | $2.5M | $1.8M | $1.6M | $1.6M | $1.9M | $1.4M | $1.2M | $6.1M | $4.8M | ||||||||||||
| Debt Conversion Converted Instrument Amount1 | |||||||||||||||||||||
| Accrued Liabilities Current | $1.4M | $985.0K | $1.1M | ||||||||||||||||||
| Accounts Payable Current | $1.0M | $814.0K | $523.0K | ||||||||||||||||||
| Repayments Of Short Term Debt | |||||||||||||||||||||
| Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current | $1.8M | $3.8M | $0.00 | $3.9M | $0.00 | ||||||||||||||||
| Debt Discount Incurred But Not Yet Recognized | |||||||||||||||||||||
| Cash | $1.9M | $3.3M | $4.4M | $5.8M | $9.2M | $12.6M | $19.2M | $17.4M | $990.0K | $6.5M | $9.3M | ||||||||||
| Adjustment To Additional Paid In Capital Debt Discount Share Settled Debt | $212.0K | $1.6M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $5.1M | $4.3M | $3.2M | $1.1M | $192.0K | $10.0K |
| Net Cash Provided By Used In Operating Activities | -$14.0M | -$14.5M | -$12.1M | -$9.9M | -$3.2M | -$600.0K |
| Net Cash Provided By Used In Financing Activities | $16.6M | $866.0K | $25.0M | $350.0K | $16.4M | $619.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$191.0K | -$243.0K | $191.0K | -$361.0K | $779.0K | $25.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $1.5M | $428.0K | -$471.0K | $1.5M | -$357.0K | $207.0K |
| Proceeds From Stock Options Exercised | $13.0K | $136.0K | $214.0K | $2.0K | $0.00 | |
| Proceeds From Issuance Of Common Stock | $730.0K | $24.8M | $348.0K | $14.7M | ||
| Net Cash Provided By Used In Investing Activities | -$600.0K | -$201.0K | -$256.0K | $0.00 | ||
| Payments To Acquire Property Plant And Equipment | $600.0K | $201.0K | $256.0K | $0.00 | ||
| Proceeds From Warrant Exercises | $0.00 | $16.0K | $0.00 | |||
| Proceeds From Convertible Debt | $0.00 | $1.7M | $617.0K | |||
| Payments To Acquire Short Term Investments | $3.8M | $0.00 | ||||
| Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities | $3.8M | $0.00 | ||||
| Proceeds From Other Short Term Debt | $0.00 | $22.0K | ||||
| Proceeds From Issuance Or Sale Of Equity | $14.7M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $1.1M | $1.2M | $393.0K | $159.0K | $9.0K | |||
| Net Cash Provided By Used In Operating Activities | -$4.5M | -$3.5M | -$3.1M | -$2.3M | -$155.0K | |||
| Net Cash Provided By Used In Financing Activities | $10.3M | $0.00 | $510.0K | $348.0K | $215.0K | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $65.0K | -$33.0K | $26.0K | $734.0K | $0.00 | |||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$44.0K | -$97.0K | $655.0K | $382.0K | -$1.0K | |||
| Proceeds From Stock Options Exercised | $100.0K | $100.0K | $16.0K | $0.00 | $0.00 | |||
| Proceeds From Issuance Of Common Stock | $10.3M | $0.00 | $494.0K | $348.0K | ||||
| Net Cash Provided By Used In Investing Activities | -$3.8M | -$88.0K | $0.00 | |||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $88.0K | $0.00 | |||||
| Proceeds From Warrant Exercises | $0.00 | $16.0K | ||||||
| Proceeds From Convertible Debt | $0.00 | $215.0K | ||||||
| Payments To Acquire Short Term Investments | $3.8M | $0.00 | ||||||
| Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities | ||||||||
| Proceeds From Other Short Term Debt | ||||||||
| Proceeds From Issuance Or Sale Of Equity | $348.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 33.7M | 26.6M | 20.3M | 8.2M | 4.3M | 3.6M |
| Weighted Average Number Of Diluted Shares Outstanding | 33.7M | 26.6M | 20.3M | 8.2M | 4.3M | 3.6M |
| Earnings Per Share Diluted | $-0.62 | $-0.73 | $-0.72 | $-1.59 | $-1.03 | $-0.29 |
| Earnings Per Share Basic | $-0.62 | $-0.73 | $-0.72 | $-1.59 | $-1.03 | $-0.29 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 20.0M |
| Common Stock Shares Outstanding | 27.0M | 27.0M | 26.3M | 8.0M | 7.8M | 3.5M |
| Common Stock Shares Issued | 40.1M | 40.1M | 27.0M | 8.0M | 7.8M | 3.5M |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 34.4M | 33.8M | 30.4M | 26.8M | 26.6M | 26.5M | 26.4M | 19.7M | 8.2M | 8.1M | 8.1M | 8.1M | 3.7M | 3.7M | 3.7M | 3.7M |
| Weighted Average Number Of Diluted Shares Outstanding | 34.4M | 33.8M | 30.4M | 26.8M | 26.6M | 26.5M | 26.4M | 19.7M | 8.2M | 8.1M | 8.1M | 8.1M | 3.7M | 3.7M | 3.7M | 3.7M |
| Earnings Per Share Diluted | $-0.15 | $-0.15 | $-0.18 | $-0.19 | $-0.19 | $-0.17 | $-0.13 | $-0.16 | $-0.50 | $-0.44 | $-0.43 | $-0.27 | $-0.32 | $-0.26 | $-0.06 | $-0.09 |
| Earnings Per Share Basic | $-0.15 | $-0.15 | $-0.18 | $-0.19 | $-0.19 | $-0.17 | $-0.13 | $-0.16 | $-0.50 | $-0.44 | $-0.43 | $-0.27 | $-0.32 | $-0.26 | $-0.06 | $-0.09 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 20.0M | 20.0M | 20.0M | 20.0M | |||
| Common Stock Shares Outstanding | 34.3M | 34.0M | 33.7M | 26.6M | 26.6M | 26.3M | 26.3M | 26.0M | 8.2M | 8.0M | 8.0M | 8.0M | 3.6M | |||
| Common Stock Shares Issued | 34.3M | 34.0M | 33.7M | 26.6M | 26.6M | 26.3M | 26.3M | 26.0M | 8.2M | 8.0M | 8.0M | 8.0M | 3.6M | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.1M | $4.3M | $3.2M | $1.1M | $192.0K | $10.0K |
| Additional Paid In Capital | $79.9M | $57.9M | $52.8M | $24.6M | $22.6M | $11.0K |
| Stock Issued During Period Value Stock Options Exercised | $13.0K | $136.0K | $214.0K | $2.0K | ||
| Stock Issued During Period Value New Issues | $10.3M | $730.0K | $24.8M | $804.0K | $14.3M | |
| Stock Issued During Period Shares Stock Options Exercised | 89.8K | 144.4K | 180.1K | 38.8K | 34.8K | 45.0K |
| Due To Related Parties Current | $1.0K | $15.0K | ||||
| Stock And Class Of Warrant Or Right Issued | $0.00 | $456.0K | $0.00 | |||
| Paycheck Protection Program Loan Forgiveness | $0.00 | $22.0K | $0.00 | |||
| Paid In Kind Interest | $0.00 | $278.0K | $248.0K | |||
| Stock Issued During Period Value Conversion Of Convertible Securities | $16.0K | $8.2M | ||||
| Interest Paid Net | $0.00 | $0.00 | $0.00 | $4.0K | ||
| Depreciation | $40.0K | $7.0K | $0.00 | |||
| Capital Expenditures Incurred But Not Yet Paid | $92.0K | $0.00 | ||||
| Accretion Expense | $0.00 | $1.9M | $0.00 | |||
| Stock Issued During Period Shares Conversion Of Convertible Securities | 1.5K | |||||
| Stock Issued1 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.4M | $1.2M | $1.1M | $1.1M | $1.0M | $1.2M | $926.0K | $702.0K | $393.0K | $351.0K | $264.0K | $159.0K | $53.0K | $23.0K | $9.0K | |
| Additional Paid In Capital | $72.4M | $70.9M | $69.3M | $56.2M | $55.1M | $54.0M | $51.6M | $50.5M | $25.5M | $24.2M | $23.9M | $23.6M | $2.0M | |||
| Stock Issued During Period Value Stock Options Exercised | $1.0K | $21.0K | $8.0K | $111.0K | $103.0K | $2.0K | ||||||||||
| Stock Issued During Period Value New Issues | $10.3M | $76.0K | $24.3M | $494.0K | $804.0K | |||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 58.8K | 0.00 | 9.2K | |||||||||||||
| Due To Related Parties Current | $1.0K | $2.0K | $1.0K | $1.0K | $3.0K | $7.0K | ||||||||||
| Stock And Class Of Warrant Or Right Issued | $0.00 | $456.0K | ||||||||||||||
| Paycheck Protection Program Loan Forgiveness | $0.00 | $22.0K | ||||||||||||||
| Paid In Kind Interest | $0.00 | $69.0K | ||||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $16.0K | |||||||||||||||
| Interest Paid Net | ||||||||||||||||
| Depreciation | $7.0K | $0.00 | ||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $2.0K | $0.00 | ||||||||||||||
| Accretion Expense | ||||||||||||||||
| Stock Issued During Period Shares Conversion Of Convertible Securities | 1.5K | |||||||||||||||
| Stock Issued1 | $456.0K | $0.00 |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.